Document Detail


Cannabinoid ligand-receptor signaling in the mouse uterus.
MedLine Citation:
PMID:  7753807     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Using RNA (Northern) blot hybridization and reverse transcription-PCR, we demonstrate that the brain-type cannabinoid receptor (CB1-R) mRNA, but not the spleen-type cannabinoid receptor (CB2-R) mRNA, is expressed in the mouse uterus and that this organ has the capacity to synthesize the putative endogenous cannabinoid ligand, anandamide (arachidonylethanolamide). The psychoactive cannabinoid component of marijuana--delta 9-tetrahydrocannabinol (THC)--or anandamide, but not the inactive and nonpsychoactive cannabidiol (CBD), inhibited forskolin-stimulated cyclic AMP formation in the mouse uterus, which was prevented by pertussis toxin pretreatment. These results suggest that uterine CB1-R is coupled to inhibitory guanine nucleotide-binding protein and is biologically active. Autoradiographic studies identified ligand binding sites ([3H]anandamide) in the uterine epithelium and stromal cells, suggesting that these cells are perhaps the targets for cannabinoid action. Scatchard analysis of the binding of [3H]WIN 55212-2, another cannabinoid receptor ligand, showed a single class of high-affinity binding sites in the endometrium with an apparent Kd of 2.4 nM and Bmax of 5.4 x 10(9) molecules per mg of protein. The gene encoding lactoferrin is an estrogen-responsive gene in the mouse uterus that was rapidly and transiently up-regulated by THC, but not by CBD, in ovariectomized mice in the absence of ovarian steroids. This effect, unlike that of 17 beta-estradiol (E2), was not influenced by a pure antiestrogen, ICI 182780, suggesting that the THC-induced uterine lactoferrin gene expression does not involve estrogen receptors. We propose that the uterus is a new target for cannabinoid ligand-receptor signaling.
Authors:
S K Das; B C Paria; I Chakraborty; S K Dey
Related Documents :
16216887 - Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagu...
11218077 - Cannabinoid cb1-mediated inhibition of stress-induced gastric ulcers in rats.
20050977 - The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a rec...
19457667 - Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 rece...
22560877 - μ-opioid and 5-ht(1a) receptors heterodimerize and show signalling crosstalk via g pro...
2997677 - Antagonism of l-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  92     ISSN:  0027-8424     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-06-16     Completed Date:  1995-06-16     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  4332-6     Citation Subset:  IM    
Affiliation:
Department of Physiology, University of Kansas Medical Center, Ralph L. Smith Research Center, Kansas City 66160-7338, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arachidonic Acids / metabolism,  pharmacology
Autoradiography
Base Sequence
Blotting, Northern
Calcium Channel Blockers / pharmacology
Cannabidiol / pharmacology
Cannabinoids / pharmacology*
Cannabis
Cyclic AMP / metabolism
DNA Primers
Female
Forskolin / pharmacology
GTP-Binding Proteins / metabolism
Gene Expression / drug effects
Mice
Mice, Inbred Strains
Molecular Sequence Data
Pertussis Toxin
Polymerase Chain Reaction
Polyunsaturated Alkamides
Pregnancy
RNA, Messenger / biosynthesis
Receptors, Cannabinoid
Receptors, Drug / biosynthesis,  physiology*
Signal Transduction*
Tetrahydrocannabinol / pharmacology
Tritium
Uterus / drug effects,  physiology*
Virulence Factors, Bordetella / pharmacology
Grant Support
ID/Acronym/Agency:
DA 06668/DA/NIDA NIH HHS; HD 12304/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Arachidonic Acids; 0/Calcium Channel Blockers; 0/Cannabinoids; 0/DNA Primers; 0/Polyunsaturated Alkamides; 0/RNA, Messenger; 0/Receptors, Cannabinoid; 0/Receptors, Drug; 0/Virulence Factors, Bordetella; 10028-17-8/Tritium; 13956-29-1/Cannabidiol; 1972-08-3/Tetrahydrocannabinol; 60-92-4/Cyclic AMP; 66428-89-5/Forskolin; 94421-68-8/anandamide; EC 2.4.2.31/Pertussis Toxin; EC 3.6.1.-/GTP-Binding Proteins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neural cell adhesion molecule (N-CAM) inhibits astrocyte proliferation after injury to different reg...
Next Document:  Oxidative DNA damage and senescence of human diploid fibroblast cells.